Pembrolizumab Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study
J. Clin. Oncol 2020 May 29;[EPub Ahead of Print], CM Rudin, MM Awad, A Navarro, M Gottfried, S Peters, T Csőszi, PK Cheema, D Rodriguez-Abreu, M Wollner, JC Yang, J Mazieres, FJ Orlandi, A Luft, M Gümüş, T Kato, GP Kalemkerian, Y Luo, V Ebiana, MC Pietanza, HR KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.